Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5275722
Max Phase: Preclinical
Molecular Formula: C19H22O6
Molecular Weight: 346.38
Associated Items:
ID: ALA5275722
Max Phase: Preclinical
Molecular Formula: C19H22O6
Molecular Weight: 346.38
Associated Items:
Canonical SMILES: C/C(=C\COc1cc(O)cc2oc(=O)ccc12)C/C=C/C(C)(C)OO
Standard InChI: InChI=1S/C19H22O6/c1-13(5-4-9-19(2,3)25-22)8-10-23-16-11-14(20)12-17-15(16)6-7-18(21)24-17/h4,6-9,11-12,20,22H,5,10H2,1-3H3/b9-4+,13-8+
Standard InChI Key: ZJGDUKAUVBWMKG-DZKPWUJRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 346.38 | Molecular Weight (Monoisotopic): 346.1416 | AlogP: 4.04 | #Rotatable Bonds: 7 |
Polar Surface Area: 89.13 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.91 | CX Basic pKa: | CX LogP: 3.52 | CX LogD: 3.40 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.34 | Np Likeness Score: 2.36 |
1. Gonçalves GA, Spillere AR, das Neves GM, Kagami LP, von Poser GL, Canto RFS, Eifler-Lima V.. (2020) Natural and synthetic coumarins as antileishmanial agents: A review., 203 [PMID:32668302] [10.1016/j.ejmech.2020.112514] |
Source(1):